0.302 USD
+0.02 (+9.03%)
0.31 USD
+0.01 (+2.65%)
ChartMill assigns a Buy % Consensus number of 83% to CUE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 5.1. This target is 1588.74% above the current price.
- CUE was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CUE.
- In the previous month the buy percentage consensus was at a similar level.
- CUE was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-25 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2025-04-02 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2024-08-20 | Stifel | Maintains | Buy -> Buy |
| 2024-07-26 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-04-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-09 | Stifel | Maintains | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-13 | Jefferies | Initiate | Buy |
| 2023-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-06-15 | Stifel | Reiterate | Buy -> Buy |
| 2023-05-15 | JMP Securities | Reiterate | Outperform -> Outperform |
| 2023-03-22 | Oppenheimer | Reiterate | Outperform |
| 2023-03-22 | Stifel | Maintains | Buy |
| 2022-11-21 | Piper Sandler | Initiate | Overweight |
| 2022-08-24 | Oppenheimer | Maintains | Outperform |
CUE BIOPHARMA INC / CUE FAQ
What is the price target for CUE stock?
6 analysts have analysed CUE and the average price target is 5.1 USD. This implies a price increase of 1588.74% is expected in the next year compared to the current price of 0.302.
Can you provide the consensus rating for CUE BIOPHARMA INC stock?
The consensus rating for CUE BIOPHARMA INC (CUE) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CUE BIOPHARMA INC (CUE) stock?
The number of analysts covering CUE BIOPHARMA INC (CUE) is 6.